Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) is offered by National Institutes of Health. Max award: $650,000. Applications close on Oct 19, 2027.
| Opportunity number | PAR-25-296 |
|---|---|
| Agency | National Institutes of Health |
| Status | Posted |
| Posted | Dec 11, 2024 |
| Closes | Oct 19, 2027 |
| Award ceiling | $650,000 |
| Award floor | Not specified |
| Total program funding | $650,000 |
| Expected awards | Not specified |
| Who can apply | Public and State controlled institutions of higher education |
| Category | Health, Income Security and Social Services |
Summary (excerpt)
The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, re…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from National Institutes of Health · Grants for Colleges and Universities